METTL3-mediated m6A mRNA modification of FBXW7 suppresses lung adenocarcinoma.

Citation metadata

Date: Mar. 6, 2021
Publisher: BioMed Central Ltd.
Document Type: Article
Length: 7,238 words
Lexile Measure: 1560L

Document controls

Main content

Abstract :

Background FBXW7 m.sup.6A modification plays an important role in lung adenocarcinoma (LUAD) progression; however, the underlying mechanisms remain unclear. Methods The correlation between FBXW7 and various genes related to m.sup.6A modification was analyzed using The Cancer Genome Atlas database. The regulatory effects of METTL3 on FBXW7 mRNA m.sup.6A modification were examined in a cell model, and the underlying mechanism was determined by methylated RNA immunoprecipitation, RNA immunoprecipitation, luciferase reporter, and mutagenesis assays. In vitro experiments were performed to further explore the biological effects of METTL3-mediated FBXW7 m.sup.6A modification on LUAD development. Results Decreased FBXW7 expression was accompanied by downregulated METTL3 expression in human LUAD tissues and was associated with a worse prognosis for LUAD in The Cancer Genome Atlas database. m.sup.6A was highly enriched in METTL3-mediated FBXW7 transcripts, and increased m.sup.6A modification in the coding sequence region increased its translation. Functionally, METTL3 overexpression or knockdown affected the apoptosis and proliferation phenotype of LUAD cells by regulating FBXW7 m.sup.6A modification and expression. Furthermore, FBXW7 overexpression in METTL3-depleted cells partially restored LUAD cell suppression in vitro and in vivo. Conclusions Our findings reveal that METTL3 positively regulates FBXW7 expression and confirm the tumor-suppressive role of m.sup.6A-modified FBXW7, thus providing insight into its epigenetic regulatory mechanisms in LUAD initiation and development. Keywords: METTL3, FBXW7, Lung adenocarcinoma, m.sup.6A, Epigenetic modification

Source Citation

Source Citation   

Gale Document Number: GALE|A655241629